Effect on rheological and some peripheral haemodynamic parameters of defibrotide in POAD patients

Received 1.12.1986; Accepted 19.1.1987 by Editor T. DiPerri) In ten POAD patients, 800 mg. of Defibrotide (polideoxynucleotide extracted from mammalian lung, with antitrombotic and fibrinolytic activity) were infused i.v. Blood and plasma viscosity, haematocrit, blood filterability and fibrinogen concentration were controlled, in basal conditions and after one hour from the end of infusion. Haemodynamic parameters: rest flow, peak flow, time to peak flow, half time and total time of reactive hyperemia by means of strain gauge pletismography, were controlled at lower limbs before infusion and after 1 h., 2 h., 6 h., from the end of infusion. The present investigation showed an improvement of rheological parameters and a decrease of total time and half time of reactive hyperemia. These data demonstrate a rheological activity of Defibrotide as well as the fibrinolytic one.

[1]  J. Bacharach.  Thrombolysis of peripheral arterial occlusion , 1993 .

[2]  G. Avellone,et al.  Clinical evaluation of short-term defibrotide treatment of patients with atherosclerosis obliterans of the lower limbs. , 1986, Haemostasis.

[3]  R. Cappelli,et al.  Defibrotide therapy for thrombophlebitis--controlled clinical trial. , 1986, Haemostasis.

[4]  G. Frascà,et al.  Effect of a new antithrombotic agent (defibrotide) in acute renal failure due to thrombotic microangiopathy. , 1985, Nephron.

[5]  M. Kerstein,et al.  Successful thrombolytic therapy for acute and chronic occlusion of polytef vascular grafts. , 1983, Archives of surgery.

[6]  M. Mantovani,et al.  Pharmacokinetics of Defibrotide and of its profibrinolytic activity in the rabbit. , 1983, Thrombosis research.

[7]  J. Hallett,et al.  Regional low dosage thrombolytic therapy for peripheral arterial occlusions. , 1983, Surgery, gynecology & obstetrics.

[8]  R. Hegyeli.  Noninvasive methods in atherosclerosis research , 1983 .

[9]  L. Beretta,et al.  Our experience in the treatment of chronic obliterative arteriopathies with urokinase , 1983 .

[10]  H. Hess,et al.  Local low-dose thrombolytic therapy of peripheral arterial occlusions. , 1982, The New England journal of medicine.

[11]  G. Folco,et al.  PGI2-generation and antithrombotic activity of orally administered defibrotide. , 1982, Pharmacological research communications.

[12]  W. Bell.  Thrombolytic therapy--a new realistic approach in treatment of thromboocclusive vascular disease. , 1982, Surgery.

[13]  G. Folco,et al.  Antithrombotic activity of a polydeoxyribonucleotidic substance extracted from mammalian organs: a possible link with prostacyclin. , 1981, Thrombosis research.

[14]  B. Katzen,et al.  Low dose streptokinase in the treatment of arterial occlusions. , 1981, AJR. American journal of roentgenology.

[15]  T. Perri.  Rheological factors in circulatory disorders. , 1979 .

[16]  T. Di Perri.  Rheological factors in circulatory disorders. , 1979, Angiology.

[17]  R. Riera,et al.  Obstructive Vascular Disease Treated by Urokinase , 1978, Medical trial technique quarterly.

[18]  M. Scully,et al.  Thrombolytic therapy. , 1968, British medical bulletin.